Prevention of neutrophil recruitment

Details Prevention of neutrophil recruitment Prevention of neutrophil recruitment

2007-06-05

2007-06-05

Carr, Deborah D. (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Fatty compounds having an acid moiety which contains the...

C554S213000, C554S227000, C558S303000, C568S022000, C568S028000, C514S553000, C514S560000, C514S706000, C514S718000

Reexamination Certificate

active

11106066

ABSTRACT:
Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.

REFERENCES:
patent: 5441951 (1995-08-01), Serhan
patent: 6433202 (2002-08-01), Serhan
patent: 6720354 (2004-04-01), Serhan
patent: 6960674 (2005-11-01), Serhan
patent: 2003/0191332 (2003-10-01), Serhan
patent: WO 98/11049 (1998-03-01), None
patent: WO 00/54761 (2000-09-01), None
patent: WO 03/039533 (2003-05-01), None
Weissmann, G. (1991)Sci. Am. 264,84-90.
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P. & Hennekens, C. H. (1997)N. Engl. J. Med. 336, 973-979.
Hennekens, C. H. (1997)N. Engl. J. Med. 336, 973-979.
Marcus, A. J. (1995)N. Engl. J. Med. 333, 656-658.
Herschmann, H.R. (1998) Trends Cardiovasc. Med. 8, 145-150.
Serhan, C. N. (1997)Prostaglandins53, 107-137.
Chiang, N., Takano, T., Clish, C. B. Petasis, N. A., Tai, H.-H. & Serhan, C. N. (1998)J. Pharmacol. Exp. Ther. 287, 779-790.
Lee, T. H., Crea, A. E., Gant, V., Spur, B. W., Marron, B. E., Nicolaou, K. C., Reardon, E., Brezinski, M. & Serhan, C. N. (1990)Am. Rev. Respir. Dis. 141, 1453-1458.
Chavis, C., Vachier, I., Chanez, P., Bousquet, J., Michael F. B. & Godard, P. (1995)Biochem. Biophys. Res. Commun. 207, 273-279.
Chavis, C., Vachier, I., Chanez, P., Bousquet, J. & Godard, P. (1996)J. Exp. Med. 183, 1633-1643.
Thomas, E., Leroux, J. L., Blotman, F. & Chavis, C. (1995)Inflamm. Res. 44, 121-124.
Gewirtz, A. T., McCormick, B., Neish, A. S., Petasis, N. A., Gronert, K., Serhan, C. N. & Madara, J. L. (1998)J. Clin. Invest. 101, 1860-1869.
Pillinger, M. H. & Abramson, S. B. (1995)Rheum. Dis. Clin. North Am. 21, 691-714.
Hagihara, H., Nomoto, A. Mutoh, S. Yamaguchi, I. & Ono, T. (1991)Atherosclerosis91, 107-116.
McLaughlan, J. M., Seth, R., Vautier, G., Robins, R. A., Scott, B. B., Hawkey, C. J. & Jenkins, D. (1997)J. Pathol. 181, 87-92.
Anezaki, K., Asakura, H., Honma, T., Ishizuka, K. Funakoshi, K., Tsukada, Y. & Narisawa, R. (1998)Intern. Med. 37, 253-258.
Iverson, L. & Kragballe, K. (1997) inSkin Immune System(SIS), ed. Bos., J. D. (CRC Press, Boca Raton), pp. 227-237.
Ensor, C. M. & Tai, H.-H. (1991) inProstaglandins, Leukotrienes, Lipoxins, and PAF, ed. Bailey, J. M. (Plenum Press, New York), pp. 39-52.
Serhan, C.N., Fiore, S., Breziski, D. A. & Lynch, S. (1993)Biochemistry32, 6313-6319.
Maddox, J. F., Colgan, S. P., Clish, C. B., Petasis, N. A., Fokin, V. V. & Serhan, C. N. (1998)FASEB J. 12, 487-494.
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady H. R., Colgan, S. P. & Madara, J. L. (1995)Biochemistry34, 14609-14615.
Takano, T. , Clish, C. B., Gronert, K. Petasis, N. & Serhan, C. N. (1998)J. Clin. Invest. 101, 819-826.
Sin, Y. M., Sedgwick, A. D., Chea, E. P. & Weilloughby, D. A. (1986)Ann. Rheum. Dis. 45, 873-877.
Bradley, P. P., Priebat, D. A., Christensen, R. D. & Rothstein, G. (1982)J. Invest. Dermatol. 78, 206-209.
Edwards, J. C. W., Sedgwick, A. D. & Willoughby, D. A. (1981)J. Pathol134, 147-156.
Tessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S. & McColl, S. R. (1997)J. Immunol, 159, 3595-3602.
Dahlen, S. E. & Serhan , C. N. (1991) inLipoxygenases and Their Products, eds. Crooke, S. T. & Wong, A. (Academic Press, San Diego, CA), pp. 235-276.
Katoh, T., Takahashi, K., DeBoer, D. K., Serhan, C. N. & Badr, K. F. (1992)Am. J. Physiol. 263, F436-442.
Marriott, J. B., Westby, M. & Dalgleish, A. G. (1997)Drug Discovery Today 2, 273-282.
Abstract No. 252676t “Neutrophil-Mediated Changes in Vascular Permeability are Inhibited by Topical Application of Aspirin-Triggered 15-epi-Lipoxin A4and Novel Lipoxin B4Stable Analogs”Chemical Abstracts, vol. 128, No. 21, p. 41, col. R, (1998).
International Search Report, Jul. 10, 2000.
European Search Report, Aug. 12, 2005.

Affiliated with

Also associated with

Rating

Prevention of neutrophil recruitment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention of neutrophil recruitment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of neutrophil recruitment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3878146